Tango Therapeutics, Inc. (TNGX)
31.56
+0.63
(+2.04%)
USD |
NASDAQ |
Jun 09, 16:00
31.78
+0.22
(+0.70%)
After-Hours: 20:00
Tango Therapeutics EPS Diluted (Quarterly) : -0.317 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Erasca, Inc. | -0.6028 |
| Kymera Therapeutics, Inc. | -0.7098 |
| NovelStem International Corp. | -0.0012 |
| Brainstorm Cell Therapeutics, Inc. | -0.1928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -45.51M |
| Total Expenses (Quarterly) | 45.51M |
| Enterprise Value | 4.112B |
| Earnings Yield | -2.60% |
| Normalized Earnings Yield | -2.598 |